Anterocollis and Camptocormia in Parkinsonism: A Current Assessment

• Published in: Current neurology and neuroscience reports Vol. 12; no. 4; pp. 386 - 391
• Main Author: Revuelta, Gonzalo J.
• Format: Journal Article
• Language: English
• Published: New York Current Science Inc 01.08.2012; Springer Nature B.V
• Subjects: 20th century; Atrophy; Clinical trials; Dopamine; Dystonia; Dystonia - etiology; Dystonia - physiopathology; Dystonia - therapy; Etiology; Humans; Hypotheses; Medicine; Medicine & Public Health; Movement Disorders (SA Factor; Muscular Atrophy, Spinal - etiology; Muscular Atrophy, Spinal - physiopathology; Muscular Atrophy, Spinal - therapy; Muscular Diseases - etiology; Muscular Diseases - physiopathology; Muscular Diseases - therapy; Neurology; Neurosciences; Orthopedics; Parkinson's disease; Parkinsonian Disorders - complications; Parkinsonian Disorders - physiopathology; Parkinsonian Disorders - therapy; Patients; Posture; Posture - physiology; Range of motion; Section Editor; Spinal Curvatures - etiology; Spinal Curvatures - physiopathology; Spinal Curvatures - therapy; Torticollis - etiology; Torticollis - physiopathology; Torticollis - therapy; Parkinsonism; Camptocormia; Dystonia; Head drop; Anterocollis; Myopathy
• ISSN: 1528-4042; 1534-6293
• DOI: 10.1007/s11910-012-0280-9

Postural deformities in parkinsonian syndromes are well recognized, but poorly understood and largely refractory to available therapies. In recent times a number of hypotheses have been proposed to explain the underlying etiology of anterocollis and camptocormia, but currently there is no consensus. As these conditions are more precisely characterized we begin to uncover that this is a heterogeneous and evolving phenomenon. These conditions bring to light the inadequacies of our current tools to study biomechanics of posture, neuromuscular disorders, and dystonic muscular contractions. The development of objective, accurate tools to directly study and measure the severity of these postural disorders will allow for further understanding of the pathophysiology, the development of novel therapeutics, and adequate clinical trial design.